Nephrocare Healt

{
  "main_header": {
    "sid": 10039897,
    "name": "Nephrocare Healt",
    "stock_name": "Nephrocare Healt",
    "full_name": "Nephrocare Health Services Ltd",
    "name_url": "stocks-analysis/nephrocare-healt",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "681.95",
    "chg": -9.85,
    "chgp": "-1.42%",
    "dir": -1,
    "prev_price": "691.80",
    "mcapval": "6,872.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544647,
    "symbol": "NEPHROPLUS",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE428V01029",
    "curr_date": "Aug 31, 03:30 PM",
    "curr_time": "20:05 PM",
    "last_traded_at": "Aug 31, 03:30 PM IST",
    "bse_nse_vol": "2.59 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 31, 2026",
    "traded_date_str": "2026 08 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nephrocare-healt-10039897-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nephrocare Health Services Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nephrocare-health-services-ltd-is-rated-sell-4166643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NephrocareHealt_mojoScore_4166643.png",
        "date": "2026-08-24 10:11:10",
        "description": "Nephrocare Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nephrocare Health Services Ltd Faces Mildly Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nephrocare-health-services-ltd-faces-mildly-bearish-momentum-amid-technical-shifts-4158981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NephrocareHealt_technicaldot_4158981.png",
        "date": "2026-08-18 08:08:36",
        "description": "Nephrocare Health Services Ltd, a small-cap player in the healthcare services sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a strong year-to-date return of 47.7%, recent technical indicators suggest caution as the stock’s momentum indicators and moving averages signal a potential cooling off after a robust rally."
      },
      {
        "title": "Nephrocare Health Services Ltd Gains 0.32%: 3 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nephrocare-health-services-ltd-gains-032-3-key-factors-driving-the-week-4154897",
        "imagepath": "",
        "date": "2026-08-15 09:00:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>10 Aug:</strong> Stock opens at Rs.696.15 with mild gains amid sideways technical momentum</p>\n                    <p><strong>11 Aug:</strong> Technical momentum shifts to mildly bearish despite 2.68% price rise to Rs.714.80</p>\n                    <p><strong>12 Aug:</strong> Sharp 4.95% decline to Rs.679.40 amid mixed technical signals and profit-taking</p>\n                    <p><strong>13 Aug:</strong> Upgrade to Hold rating by MarketsMOJO on improved financials and stabilising technicals</p>\n                    <p><strong>14 Aug:</strong> Price rebounds 3.09% to Rs.696.45, closing the week on a positive note</p>\n                </div>\n\n                <div class=\"stats-row\">\n ..."
      },
      {
        "title": "Nephrocare Health Services Ltd Upgraded to Hold on Improved Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nephrocare-health-services-ltd-upgraded-to-hold-on-improved-financial-and-technical-metrics-4151292",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NephrocareHealt_mojoScore_4151292.png",
        "date": "2026-08-13 08:41:22",
        "description": "Nephrocare Health Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across financial performance, valuation metrics, technical indicators, and overall quality. The healthcare services company’s recent quarterly results and market trends have prompted a reassessment of its outlook, signalling cautious optimism among investors and analysts alike."
      },
      {
        "title": "Nephrocare Health Services Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nephrocare-health-services-ltd-technical-momentum-shifts-amid-mixed-market-signals-4151167",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NephrocareHealt_technicaldot_4151167.png",
        "date": "2026-08-13 08:04:02",
        "description": "Nephrocare Health Services Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent day decline of 4.95%, the stock’s year-to-date return of 44.78% significantly outpaces the Sensex’s negative 8.51%, signalling underlying strength amid short-term volatility."
      },
      {
        "title": "Are Nephrocare Health Services Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-nephrocare-health-services-ltd-latest-results-good-or-bad-4148668",
        "imagepath": "",
        "date": "2026-08-11 19:29:11",
        "description": "Nephrocare Health Services Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape characterized by strong revenue growth alongside margin pressures. The company reported net sales of ₹265.62 crores, representing a year-on-year increase of 34.65% from ₹219.19 crores in Q4 FY25, indicating robust demand and successful execution of its expansion strategy in India's dialysis market. However, the sequential growth in revenue moderated to 2.27% from the previous quarter, suggesting a stabilization phase after aggressive expansion.\n\nNet profit for the quarter stood at ₹30.37 crores, which is a significant year-on-year improvement of 51.02% compared to ₹24.87 crores in Q4 FY25. Despite this positive trend, the net profit showed a sequential decline of 5.80% from ₹32.24 crores in Q3 FY26, highlighting some volatility in profitability metrics.\n\nOperating margins, however, faced challenges,..."
      },
      {
        "title": "Nephrocare Health Services Ltd: Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nephrocare-health-services-ltd-technical-momentum-shifts-amid-mixed-signals-4146624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NephrocareHealt_technicaldot_4146624.png",
        "date": "2026-08-11 08:09:25",
        "description": "Nephrocare Health Services Ltd, a small-cap player in the healthcare services sector, has recently experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.28%, the company’s technical indicators present a nuanced picture, with some signals suggesting caution for investors amid a backdrop of strong year-to-date returns outperforming the Sensex."
      },
      {
        "title": "Nephrocare Health Services Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nephrocare-health-services-ltd-is-rated-sell-4144006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NephrocareHealt_mojoScore_4144006.png",
        "date": "2026-08-09 10:10:28",
        "description": "Nephrocare Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Nephrocare Health Services Ltd Technical Momentum Shifts Amid Sideways Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nephrocare-health-services-ltd-technical-momentum-shifts-amid-sideways-trend-4135654",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NephrocareHealt_technicaldot_4135654.png",
        "date": "2026-08-04 08:11:56",
        "description": "Nephrocare Health Services Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a modest day gain of 0.79%, the stock’s technical indicators reveal a complex picture, with mixed signals from MACD, RSI, and moving averages, underscoring a cautious outlook for investors in this small-cap healthcare services company."
      }
    ],
    "total": 57,
    "sid": "10039897",
    "stock_news_url": "https://www.marketsmojo.com/news/nephrocare-health-services-10039897"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "19-Aug-2026",
      "details": "Please find enclosed herewith Transcripts for the investors Earning call held on August 12 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
      "datetime": "17-Aug-2026",
      "details": "Pursuant to Reg 30 of SEBI Listing Regulations we hereby inform that Nephrocare Health Services Phillipines Inc. a step-down wholly-owned subsidiary of the Company has acquired a dialysis centre and has executed an ATA as per the disclosure annexed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "13-Aug-2026",
      "details": "Declartion of voting results along with scrutinizers report of the 17th AGM of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nephrocare Health Services Ltd is Rated Sell

2026-08-24 10:11:10

Nephrocare Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Nephrocare Health Services Ltd Faces Mildly Bearish Momentum Amid Technical Shifts

2026-08-18 08:08:36

Nephrocare Health Services Ltd, a small-cap player in the healthcare services sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a strong year-to-date return of 47.7%, recent technical indicators suggest caution as the stock’s momentum indicators and moving averages signal a potential cooling off after a robust rally.

Read full news article

Nephrocare Health Services Ltd Gains 0.32%: 3 Key Factors Driving the Week

2026-08-15 09:00:52

Key Events This Week

10 Aug: Stock opens at Rs.696.15 with mild gains amid sideways technical momentum

11 Aug: Technical momentum shifts to mildly bearish despite 2.68% price rise to Rs.714.80

12 Aug: Sharp 4.95% decline to Rs.679.40 amid mixed technical signals and profit-taking

13 Aug: Upgrade to Hold rating by MarketsMOJO on improved financials and stabilising technicals

14 Aug: Price rebounds 3.09% to Rs.696.45, closing the week on a positive note

...

Read full news article

Nephrocare Health Services Ltd Upgraded to Hold on Improved Financial and Technical Metrics

2026-08-13 08:41:22

Nephrocare Health Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across financial performance, valuation metrics, technical indicators, and overall quality. The healthcare services company’s recent quarterly results and market trends have prompted a reassessment of its outlook, signalling cautious optimism among investors and analysts alike.

Read full news article

Nephrocare Health Services Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-13 08:04:02

Nephrocare Health Services Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent day decline of 4.95%, the stock’s year-to-date return of 44.78% significantly outpaces the Sensex’s negative 8.51%, signalling underlying strength amid short-term volatility.

Read full news article

Are Nephrocare Health Services Ltd latest results good or bad?

2026-08-11 19:29:11

Nephrocare Health Services Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape characterized by strong revenue growth alongside margin pressures. The company reported net sales of ₹265.62 crores, representing a year-on-year increase of 34.65% from ₹219.19 crores in Q4 FY25, indicating robust demand and successful execution of its expansion strategy in India's dialysis market. However, the sequential growth in revenue moderated to 2.27% from the previous quarter, suggesting a stabilization phase after aggressive expansion. Net profit for the quarter stood at ₹30.37 crores, which is a significant year-on-year improvement of 51.02% compared to ₹24.87 crores in Q4 FY25. Despite this positive trend, the net profit showed a sequential decline of 5.80% from ₹32.24 crores in Q3 FY26, highlighting some volatility in profitability metrics. Operating margins, however, faced challenges,...

Read full news article

Nephrocare Health Services Ltd: Technical Momentum Shifts Amid Mixed Signals

2026-08-11 08:09:25

Nephrocare Health Services Ltd, a small-cap player in the healthcare services sector, has recently experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.28%, the company’s technical indicators present a nuanced picture, with some signals suggesting caution for investors amid a backdrop of strong year-to-date returns outperforming the Sensex.

Read full news article

Nephrocare Health Services Ltd is Rated Sell

2026-08-09 10:10:28

Nephrocare Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Nephrocare Health Services Ltd Technical Momentum Shifts Amid Sideways Trend

2026-08-04 08:11:56

Nephrocare Health Services Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a modest day gain of 0.79%, the stock’s technical indicators reveal a complex picture, with mixed signals from MACD, RSI, and moving averages, underscoring a cautious outlook for investors in this small-cap healthcare services company.

Read full news article

View All News